RETIRED: The Use of Magnetic Resonance Imaging in the Obstetric Patient
| Autor: | Yves Patenaude, Denise Pugash, Kenneth Lim, Lucie Morin, Stephen Bly, Kimberly Butt, Yvonne Cargill, Gregory Davies, Nanette Denis, Gail Hazlitt, Kentia Naud, Annie Ouellet, Shia Salem |
|---|---|
| Rok vydání: | 2014 |
| Předmět: |
Gadolinium DTPA
medicine.medical_specialty Specialty MEDLINE Contrast Media Placenta Accreta Congenital Abnormalities law.invention Fetus Randomized controlled trial Pregnancy law Humans Medicine business.industry Infant Newborn Obstetrics and Gynecology Health technology Guideline medicine.disease Magnetic Resonance Imaging Pregnancy Complications Clinical trial Fetal Diseases Breast Feeding Systematic review Female Observational study Patient Safety Pregnancy Trimesters Medical emergency Radiology business |
| Zdroj: | Journal of Obstetrics and Gynaecology Canada. 36:349-355 |
| ISSN: | 1701-2163 |
| DOI: | 10.1016/s1701-2163(15)30612-5 |
| Popis: | Objective To review the biological effects and safety of magnetic resonance imaging (MRI) in the obstetric patient and to review procedural issues, indications, and contraindications for obstetrical MRI. Outcomes This guideline is intended to reassure patients and clinicians of the safety of MRI in pregnancy and to provide a framework for its use. Evidence Published literature was retrieved through searches of PubMed or Medline in 2013 using controlled vocabulary and key words (e.g., MRI, safety, pregnancy). Results were restricted to systematic reviews, randomized control trials/controlled clinical trials, and observational studies published in English and in French. There were no date restrictions. Searches were updated on a regular basis and incorporated in the guideline to July 2013. Grey (unpublished) literature was identified through searching the websites of health technology assessment and health technology-related agencies, clinical practice guideline collections, clinical trial registries, and national and international medical specialty societies. Values The quality of evidence in this document was rated using the criteria described in the Report of the Canadian Task Force on Preventive Health Care (Table). Benefits, harms, and costs This article is intended to reassure obstetric care providers that if used in an appropriate manner without the use of contrast agents, MRI in the obstetrical patient is safe for mother and fetus in the second and third trimesters. Because obstetrical MRI is expensive and has limited availability in Canada, this clinical guideline is intended to encourage the judicious use of this resource. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|